CN Patent

CN121754493A — 布鲁顿氏酪氨酸激酶抑制剂的医药配方

Assigned to Pharmacyclics LLC · Expires 2026-03-31 · 0y expired

What this patent protects

本申请涉及布鲁顿氏酪氨酸激酶抑制剂的医药配方。本文描述了布鲁顿氏酪氨酸激酶（Btk）抑制剂1‑((R)‑3‑(4‑氨基‑3‑(4‑苯氧基苯基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)哌啶‑1‑基)丙‑2‑烯‑1‑酮的医药配方。还公开了使用单独或与其它治疗剂组合的Btk抑制剂用于治疗自体免疫疾病或病状、异种免疫疾病或病状、癌症（包括淋巴瘤）以及发炎性疾病或病状的方法。

USPTO Abstract

本申请涉及布鲁顿氏酪氨酸激酶抑制剂的医药配方。本文描述了布鲁顿氏酪氨酸激酶（Btk）抑制剂1‑((R)‑3‑(4‑氨基‑3‑(4‑苯氧基苯基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)哌啶‑1‑基)丙‑2‑烯‑1‑酮的医药配方。还公开了使用单独或与其它治疗剂组合的Btk抑制剂用于治疗自体免疫疾病或病状、异种免疫疾病或病状、癌症（包括淋巴瘤）以及发炎性疾病或病状的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN121754493A
Jurisdiction
CN
Classification
—
Expires
2026-03-31
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacyclics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.